Akebia Therapeutics, Inc. (AKBA)
1.425
+0.02
(+1.06%)
USD |
NASDAQ |
Apr 22, 16:00
1.425
0.00 (0.00%)
After-Hours: 16:57
Akebia Therapeutics Shareholders Equity (Quarterly) : 32.61M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| MannKind Corp. | -51.02M |
| Ligand Pharmaceuticals, Inc. | 1.017B |
| Ardelyx, Inc. | 166.95M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 376.56M |
| Total Liabilities (Quarterly) | 343.96M |
| Debt to Equity Ratio | 6.633 |
| Current Ratio | 1.552 |
| Net Debt Paydown Yield | -1.18% |